Depletion of the tetra-transmembrane protein CMTM4 sensitizes tumor cells to EGFR inhibition and limits tumor growth by reducing the production of inflammatory cytokines and the recruitment of immune-suppressive cells. This evidence concerns the gene EGFR and neoplasm.